James A Eastham
Overview
Explore the profile of James A Eastham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
327
Citations
13834
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leni R, Vertosick E, Liso N, Akin O, Carlsson S, Montorsi F, et al.
Eur Urol Open Sci
. 2025 Mar;
72:46-53.
PMID: 40034920
Background And Objective: Guideline recommendations regarding early management of grade group (GG) 2 prostate cancer with confirmatory biopsy (cBx) are not well established. Our aim was to determine which patients...
2.
Scuderi S, Tin A, Klug J, Porwal S, Quarta L, Ciabattini M, et al.
J Urol
. 2025 Feb;
:101097JU0000000000004484.
PMID: 39977387
Purpose: International Society of Urological Pathology (ISUP) Grade Group (GG) is based on the relative proportion of Gleason patterns 3 and 4. We investigated whether absolute pattern 4 volume is...
3.
Touijer K, Vertosick E, Sjoberg D, Liso N, Nalavenkata S, Melao B, et al.
Eur Urol
. 2024 Oct;
87(2):253-260.
PMID: 39472200
Background And Objective: Lymph node dissection (LND) has been standard in cancer surgery for more than a century, yet evidence from randomized trials showing a benefit is scarce. We conducted...
4.
Underwood W, Michalski M, Lee C, Fickera G, Chun S, Eng S, et al.
NPJ Digit Med
. 2024 Oct;
7(1):304.
PMID: 39468290
We developed and evaluated the Digital Platform for Exercise (DPEx): a decentralized, patient-centric approach designed to enhance all aspects of clinical investigation of exercise therapy. DPEx integrated provision of a...
5.
Perera M, Assel M, Nalavenkata S, Khaleel S, Benfante N, Carlsson S, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(6):102204.
PMID: 39260095
Background: During active surveillance (AS) for Grade Group (GG) 2 prostate cancer, pathologic progression to GG3 on surveillance biopsy is a trigger for intervention. However, this ratio of GP3:GP4, may...
6.
Jones L, Moskowitz C, Lee C, Fickera G, Chun S, Michalski M, et al.
JAMA Oncol
. 2024 Jul;
10(9):1187-1194.
PMID: 39023900
Importance: Observational data have shown that postdiagnosis exercise is associated with reduced risk of prostate cancer death. The feasibility and tumor biological activity of exercise therapy is not known. Objective:...
7.
Schaeffer E, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al.
J Natl Compr Canc Netw
. 2024 Apr;
22(3):140-150.
PMID: 38626801
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic...
8.
Wilcox Vanden Berg R, Vertosick E, Sjoberg D, Cha E, Coleman J, Donahue T, et al.
Eur Urol Open Sci
. 2024 Mar;
62:81-90.
PMID: 38468865
Background: Surgical education lacks a standardized, proficiency-based approach to evaluation and feedback. Objective: To assess the implementation and reception (ie, feasibility) of an automated, standardized, longitudinal surgical skill assessment and...
9.
Flores J, Vertosick E, Jenkins L, Cooper J, Benfante N, Sjoberg D, et al.
J Urol
. 2024 Jan;
211(3):400-406.
PMID: 38194487
Purpose: There have been conflicting studies on the association between phosphodiesterase type 5 inhibitor (PDE5i) use and biochemical recurrence (BCR) following radical prostatectomy (RP). Our aim was to determine whether...
10.
Mahal B, Kwak L, Xie W, Eastham J, James N, Sandler H, et al.
JAMA Netw Open
. 2023 Nov;
6(11):e2340787.
PMID: 37910103
Importance: Patients with high-grade prostate cancer with low levels of prostate-specific antigen (PSA; <4 ng/mL) are at high risk of mortality, necessitating an improved treatment paradigm. Objective: To assess for...